*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Effect of progestogen supplementation early in pregnancy With postdate labour and failure of labor induction among them

Author: DR. ABDUL, DR. SHYAMAA ABD HASSAN, DR. REEM ALI HADDAD
Abstract: In obstetrics field, progesterone is used for too many indications like: pregnancy support in IVF cycles (12), treatment of threatened abortion (13), or in the prevention of recurrent abortion (14), though results showed no evidence to support routine use in the last two indications. Several observations have been made in clinical practice that patients receiving progesterone (usually synthetic form called progestogen) early in pregnancy for any of the abovementioned indications usually fail to have spontaneous labor at 40 weeks ( due date of delivery), a time considered to be the starting point for initiation of management of the possible postterm labor with all its inherent complications (2); observations have also been made that supplemented pregnants show failure of labor induction trials at 41 weeks and hence higher caesarian delivery rates with its complications. No previous studies ( regional or global) have been made searching the existence of this relationship. In our study cohort design was implemented on 95 patients searching for the role of progesterone supplementation early in pregnancy in predisposing to the above obstetrical complications. Results of our study proved that this supplementation is risky for prolongation of pregnancy beyond 40 weeks ( RR: 2.611, df: 1, P value: 0.117), as well as failure to induce labour among them ( RR: 1.875, Fisher exact: 0.424, P value: 0.545). In view results we recommend searching the effect on a larger study sample, but in the meanwhile restriction of widened use of supplement prescription among pregnants is to be considered.
Keyword: progestogen,
DOI: https://doi.org/10.31838/ijpr/2018.10.04.060
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free